SFF
The pharmaceutical and biopharmaceutical industries are witnessing a growing demand for sterile manufacturing, driven by the increasing prevalence of injectable therapies such as vaccines, cell and gene therapies and complex biologics.
Producing sterile therapeutics requires careful consideration of container formats to ensure their safe and effective delivery. Selecting the appropriate container is crucial for maintaining product quality and optimising patient outcomes. It requires developers to assess many different factors, including patient safety, convenience, cost-effectiveness and sustainability.
In a recent article for The Medicine Maker, Vincenza Pironti, Recipharm’s Head of Business Development, delves into the evolving landscape of therapeutic container formats.
She examines how shifting industry demands, a growing emphasis on patient-centricity, and continuous advancements in container technologies are shaping the evolution of drug packaging. Offering her unique insights, she also explores the key trends and innovations that are poised to redefine the future of drug delivery, including:
- PFS advancements expanding their applications and usability
- BFS technologies safeguarding sterility and cost-effectiveness
- Vial innovations overcoming breakage and leaching risks.